Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

2.

Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model.

Lahiri DK, Zawia NH, Greig NH, Sambamurti K, Maloney B.

Biogerontology. 2008 Dec;9(6):375-9. doi: 10.1007/s10522-008-9162-6. Epub 2008 Jul 31. Review.

3.

Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model.

Maloney B, Sambamurti K, Zawia N, Lahiri DK.

Curr Alzheimer Res. 2012 Jun;9(5):589-99. Review.

PMID:
22300406
4.

Environmental risk factors and the developmental basis for Alzheimer's disease.

Zawia NH, Basha MR.

Rev Neurosci. 2005;16(4):325-37. Review.

PMID:
16519009
5.

Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

Sambamurti K, Granholm AC, Kindy MS, Bhat NR, Greig NH, Lahiri DK, Mintzer JE.

Curr Drug Targets. 2004 Aug;5(6):517-28. Review.

PMID:
15270198
6.

The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.

Rocchi A, Orsucci D, Tognoni G, Ceravolo R, Siciliano G.

Curr Alzheimer Res. 2009 Jun;6(3):224-37. Review.

PMID:
19519304
7.
8.

The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW, Lahiri DK, Zawia NH.

J Neurosci. 2005 Jan 26;25(4):823-9.

9.

Environmental and dietary risk factors in Alzheimer's disease.

Dosunmu R, Wu J, Basha MR, Zawia NH.

Expert Rev Neurother. 2007 Jul;7(7):887-900. Review.

PMID:
17610395
10.

Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation.

Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, Lashuel HA, Ge YW, Lahiri DK, Zawia NH.

FASEB J. 2005 Dec;19(14):2083-4. Epub 2005 Oct 17.

PMID:
16230335
11.
12.

Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Cacabelos R.

Mol Diagn Ther. 2007;11(6):385-405. Review.

PMID:
18078356
13.

Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

Bartzokis G.

Neurobiol Aging. 2004 Jan;25(1):5-18; author reply 49-62. Review.

PMID:
14675724
14.

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW.

Neuroscience. 2009 Sep 29;163(1):55-72. doi: 10.1016/j.neuroscience.2009.05.071. Epub 2009 Jun 14.

PMID:
19500657
15.

The environment, epigenetics and amyloidogenesis.

Wu J, Basha MR, Zawia NH.

J Mol Neurosci. 2008;34(1):1-7. Epub 2007 Apr 17. Review.

PMID:
18157652
16.
17.

Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation.

Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, Stone W, Glatt SJ, Tsuang MT.

Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):51-9.

PMID:
15108180
18.

Etiology and pathogenesis of Alzheimer's disease.

Farlow MR.

Am J Health Syst Pharm. 1998 Nov 1;55 Suppl 2:S5-10. Review. Erratum in: Am J Health Syst Pharm 1998 Dec 15;55(24):2640.

PMID:
9809105
19.

Early-onset Alzheimer's disease in Scotland: environmental and familial factors.

Whalley LJ.

Br J Psychiatry Suppl. 2001 Apr;40:s53-9. Review.

PMID:
11315226
20.

Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility.

Theuns J, Van Broeckhoven C.

Hum Mol Genet. 2000 Oct;9(16):2383-94. Review.

PMID:
11005793

Supplemental Content

Support Center